Bristol-Myers Squibb: all 2,184 studies
Page 14 of 22. Open to participants first (162), then studies with results posted, then the rest; newest registration first within each.
- Treatment Patterns, Clinical Outcomes, and Healthcare Resource Utilization Associated With Chinese Patients With Advanced Lung CancerCompletedNCT03505515
- Effectiveness, Safety and Use of Nivolumab Administered During the French Temporary Authorization for Use in Patients With Advanced MelanomaCompletedNCT03504696
- Study of Daclatasvir-based Therapy in Chinese Participants With Chronic Hepatitis C (CHC)TerminatedNCT03500562
- Study of CC-93269, a BCMA x CD3 T Cell Engaging Antibody, in Participants With Relapsed and Refractory Multiple MyelomaTerminatedNCT03486067Phase 1
- Study of the Safety of Orencia in Japanese Children and Adolescents With Active Juvenile Arthritis of Unknown OriginCompletedNCT03466814
- A Study of Abatacept in Participants That Only Recently Started to Develop Rheumatoid ArthritisCompletedNCT03457792
- Non-Interventional Study (NIS) of Nivolumab With or Without Ipilimumab in Participants With Advanced Kidney CancerCompletedNCT03455452
- Long Term Quality of Life in Melanoma Patients in NetherlandsCompletedNCT03450876
- Study of First-line Treatment Patterns and Clinical Outcomes in Patients With Advanced Melanoma in the United KingdomCompletedNCT03448497
- A Study of Experimental Medication BMS-986036 Given to Healthy ParticipantsCompletedNCT03445208Phase 1
- An Investigational Immunotherapy Study of BMS-986299 Alone and in Combination With Nivolumab and Ipilimumab in Participants With Solid Cancers That Have Spread or Cannot be RemovedTerminatedNCT03444753Phase 1
- Survival Study for Participants Treated With Ipilimumab-Nivolumab Combination TherapyCompletedNCT03438279
- Long-term Follow-up Study for Patients Previously Treated With a Juno CAR T-Cell ProductTerminatedNCT03436771
- Survival in Patients Older Than 60 Years With Newly Diagnosed AML in SpainCompletedNCT03435341
- A Study of Experimental Medication BMS-986278 Given to Healthy ParticipantsCompletedNCT03429933Phase 1
- A Real-World Observational Study for the Safety and Efficacy of Baraclude in Korean Pediatric Patients With Chronic Hepatitis BCompletedNCT03426618
- Treatment Patterns in Advanced Small Cell Lung Cancer (SCLC)CompletedNCT03425825
- An Investigational Study of Cyclosporine on Experimental Medication BMS-986165 in Healthy Male ParticipantsCompletedNCT03419910Phase 1
- Safety and Effectiveness of Abatacept in Psoriatic Arthritis ParticipantsCompletedNCT03419143
- An Immuno-Therapy Study of Experimental Medication BMS-986205 Given With Nivolumab With or Without Chemotherapy Compared to Chemotherapy in Participants With Previously Untreated Stage IV or Recurrent Non-Small Cell Lung CancerWithdrawnNCT03417037Phase 3
- A Dose-Escalation Study of MDX-010 Administered Monthly as Immunotherapy in Subjects Infected With Human Immunodeficiency Virus (HIV)CompletedNCT03407105Phase 1
- A Study to Investigate BMS-986165 and Methotrexate in Healthy Male PatientsCompletedNCT03402087Phase 1
- An Immuno-therapy Study of Nivolumab in Combination With Experimental Medication BMS-986205 Compared to Standard of Care EXTREME Regimen in First-line Recurrent/Metastatic Squamous Cell Carcinoma of Head and NeckWithdrawnNCT03386838Phase 3
- A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or AblationActive, not recruitingNCT03383458Phase 3
- Observational Study for Lung Cancer Patients Treated With NivolumabCompletedNCT03382496
- A Study in Healthy Participants Evaluating the Absorption of a BMS-986205 Tablet Into the Bloodstream Compared to a Reference TabletCompletedNCT03378310Phase 1
- A Study Using Healthy Volunteers Comparing Belatacept Which Has Been Manufactured By 2 Different ProcessesCompletedNCT03375138Phase 1
- A Study to Evaluate the Bioavailability of BMS-986205CompletedNCT03374228Phase 1
- A Safety, PK and Efficacy Study of CC-92480 Monotherapy and in Combination With Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM)TerminatedNCT03374085Phase 1/2
- Study to Assess Clinical Outcomes in Chronic Hepatitis C Patients Previously Treated With Daclatasvir-Based RegimensCompletedNCT03366610
- A Study to Evaluate the Effect of Multiple Doses of CC-90001 on the Pharmacokinetics of Omeprazole, Midazolam, Warfarin, Rosuvastatin, Metformin, Digoxin, and Nintedanib in Healthy Adult SubjectsCompletedNCT03363815Phase 1
- Evaluate the Pharmacokinetics of BMS-986177 From Two Formulations in Healthy ParticipantsCompletedNCT03362437Phase 1
- A Study to Assess the Absorption of a Single Dose of BMS-986205 in Healthy Volunteers When Administered as a Crushed Tablet Orally or Crushed Tablet Suspension Via Nasogastric Tube, as Compared to a TabletCompletedNCT03362411Phase 1
- A Study to Evaluate the Effect of 2 Drugs on the Pharmacokinetics of BMS-986205 in Healthy SubjectsCompletedNCT03346837Phase 1
- An Investigational Study to Assess the Effect of BMS-986177 on Aspirin in Healthy ParticipantsCompletedNCT03341390Phase 1
- Study Evaluating the Effects of Food, Cytochrome P450 Inhibition and Induction on the Pharmacokinetics of CC-122CompletedNCT03340662Phase 1
- Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of CC-90006 in Subjects With Mild to Moderate Plaque-type PsoriasisCompletedNCT03337022Phase 1
- A Study of Experimental Medication BMS-986235 in Healthy SubjectsCompletedNCT03335553Phase 1
- An Adaptive Study to Match Patients With Solid Tumors to Various Immunotherapy Combinations Based Upon a Broad Biomarker AssessmentCompletedNCT03335540Phase 1
- A Study of Experimental Medication BMS-986231 in Patients With Different Levels of Kidney FunctionCompletedNCT03332186Phase 1
- The Value of Orencia in Rapidly Progressing Rheumatoid ArthritisCompletedNCT03331393
- Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)Active, not recruitingNCT03331198Phase 1/2
- A Study to Estimate the Effect Sizes of HRCT Endpoints in Response to Glucocorticoid Induction Therapy in Subjects With Pulmonary SarcoidosisCompletedNCT03324503Not applicable
- Screening for Atrial Fibrillation (AF)-Potential Patients to Increase AF Detection RateCompletedNCT03313167
- An Investigational Study to Assess the Effect of a Light Meal and a High-Fat Meal on the Absorption of BMS-986205 in Healthy ParticipantsCompletedNCT03312426Phase 1
- Radiolabeled Study of CC-220 in Healthy Male SubjectsCompletedNCT03294603Phase 1
- A Study to Assess the Pharmacokinetics of Enasidenib (CC-90007) in Subjects With Moderate and Severe Hepatic Impairment.CompletedNCT03290443Phase 1
- Post Marketing Surveillance on Safety Evaluation of POMALYST® (Pomalidomide) Treatment of Multiple Myeloma in KoreaCompletedNCT03288974
- Study of Safety and Efficacy of Avadomide (CC-122) Combined With RCHOP for Newly-diagnosed DLBCL With Poor Risk FactorsCompletedNCT03283202Phase 1
- A Study of BMS-986224 in Healthy Subjects and Heart Failure Patients With Reduced Ejection FractionTerminatedNCT03281122Phase 1
- Study of bb21217 in Multiple MyelomaCompletedNCT03274219Phase 1
- Comparing the Effectiveness of a Treat-to-target (T2T) Disease Management Strategy vs. Routine Care (RC) in Adult Patients With Moderate to Severe Rheumatoid Arthritis (RA) Treated With Subcutaneous Abatacept (Orencia - SC)CompletedNCT03274141
- A Retrospective Study of the Effectiveness and Safety of Nivolumab in Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients in JapanCompletedNCT03273790
- The Effect of BMS-986195 Combined With an Oral Contraceptive (Ethinyl Estradiol/Norethindrone) in Healthy Female PatientsCompletedNCT03262740Phase 1
- The Effect of BMS-986165 Combined With an Oral Contraceptive (Ethinyl Estradiol/Norethindrone) in Healthy Female PatientsCompletedNCT03262727Phase 1
- A Study to Evaluate BMS-986165 Tablet Formulation Relative to BMS-986165 Capsule Formulation and the Effect of a High-Fat/ High-Calorie Meal and Increased Gastric pH on the BMS-986165 Tablet FormulationCompletedNCT03254784Phase 1
- Pharmacokinetics and Metabolism Study in Healthy Male ParticipantsCompletedNCT03247283Phase 1
- A Study of BMS-986195 in Healthy Male SubjectsCompletedNCT03245515Phase 1
- A Study of Safety, Tolerability, and the Effects Two ND-L02-s0201 Have on the BodyCompletedNCT03241264Phase 1
- To Evaluate the Safety and Pharmacokinetics of BMS-986177 in Healthy Japanese ParticipantsCompletedNCT03224260Phase 1
- A Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of CC-90010 in Subjects With Advanced Solid Tumors and Relapsed/Refractory Non-Hodgkin's LymphomasTerminatedNCT03220347Phase 1
- Pharmacokinetics and Metabolism of [14C] BMS-986231 in Healthy Male ParticipantsCompletedNCT03210909Phase 1
- Early Post-marketing Study of Daclatasvir (Daklinza®) + Asunaprevir (Sunvepra®) in the Treatment of Chronic Hepatitis C (CHC) in AdultsWithdrawnNCT03208322
- The Effectiveness of Nivolumab Monotherapy as First-Line Therapy in Adults With Advanced Melanoma in GermanyWithdrawnNCT03205722
- A Retrospective, Observational Study on the Effectiveness of Daclatasvir-Containing Regimens in Patients in KSA, UAE and QatarCompletedNCT03205618
- A Safety Study of Lirilumab in Combination With Nivolumab or in Combination With Nivolumab and Ipilimumab in Advanced and/or Metastatic Solid TumorsCompletedNCT03203876Phase 1
- Safety of Allogeneic Hematopoietic Cell Transplantation (HCT) For Patients With Classical Hodgkin Lymphoma (CHL) Treated With NivolumabCompletedNCT03200977
- Treatment Patterns and Outcomes Study in Patients With Unresectable Stage III and Metastatic (Stage IV) Melanoma in the United StatesCompletedNCT03199846
- A Study to Test the Effects of BMS-986036 on the Body in Healthy Japanese and Non-Japanese SubjectsCompletedNCT03198182Phase 1
- A Study of Pharmacokinetics (PK) and Pharmacodynamics (PD) in Relation to Prednisolone in Healthy MalesCompletedNCT03198013Phase 1
- A Short and Long Intravenous Infusion Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-962212 in Healthy SubjectsCompletedNCT03197779Phase 1
- A Study to Assess the Pharmacodynamics (PD) of Prednisoline in Healthy Male SubjectCompletedNCT03196557Phase 1
- Evaluate Pharmacokinetics and Safety of BMS-986177 in Participants With Normal Renal Function and With Moderate or Severe Renal ImpairmentCompletedNCT03196206Phase 1
- A Study to Evaluate Efficacy and Safety of Subcutaneous Abatacept With Steroid Treatment Compared to Steroid Treatment Alone in Adults With Giant Cell Arteritis (GCA)WithdrawnNCT03192969Phase 3
- A Study of BMS-986205 Given in Combination With Nivolumab in Patients With Advanced TumorsCompletedNCT03192943Phase 1
- A Real-World Comparison of Safety and Effectiveness of Novel Oral Anti-Coagulant (NOAC) Naïve and Warfarin Naïve Non-Valvular Atrial Fibrillation (NVAF) Patients With Medicare Advantage CoverageCompletedNCT03189069
- A Study to Investigate the Effectiveness of an Education Support Program on Medication Adherence in Italian Real Life Rheumatoid Arthritis (RA) Patients Treated With Subcutaneous (SC) AbataceptCompletedNCT03188081
- Early Post-marketing Study of Daclatasvir (Daklinza) in the Treatment of Chronic Hepatitis C (CHC) in AdultsCompletedNCT03181074
- A Real-World Study of Ipilimumab Treatment After Nivolumab Treatment in Melanoma in JapanCompletedNCT03165422
- Cost of Adverse Events Related to How Often Follow-Up Occurs Among Patients With Cancer That Has SpreadCompletedNCT03165409
- Study to Assess the Safety of Nivolumab in the Treatment of Metastatic Melanoma, Lung Cancer, Renal Cancer, Squamous Cell Carcinoma of the Head and Neck, and Chronic Hodgkin Lymphoma in Adults in MexicoWithdrawnNCT03161613
- A Study to Observe the Treatment Patterns and Outcomes of Patients in Japan With Kidney Cancer That is Unable to be Removed by Surgery or That Has SpreadCompletedNCT03161145
- Real-World Evidence and Treatment Patterns: Head and Neck CancerCompletedNCT03157674
- A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986263 in Healthy ParticipantsCompletedNCT03142165Phase 1
- A Study to Assess the Relative Bioavailability of a New CC-220 Capsule Formulation, Compared to a Reference CC-220 Capsule Formulation, in Healthy Adult SubjectsCompletedNCT03135509Phase 1
- Effects of Concomitant Administration of BMS-986195 on Methotrexate, Caffeine, Montelukast, Flurbiprofen, Omeprazole, Midazolam, Digoxin, and PravastatinCompletedNCT03131973Phase 1
- Expanded Access to Nivolumab (Opdivo)Approved for marketingNCT03126643
- Expanded Access to Elotuzumab (Empliciti) for Multiple MyelomaNo longer availableNCT03126617
- Observational Study of Nivolumab in Participants in Germany With Squamous Cell Carcinoma of the Head and Neck (SCCHN) Progressing on or After Platinum-Based TherapyCompletedNCT03114163
- A Safety Study of Lenalidomide in Previously Untreated Adult Multiple Myeloma Patients Who Are Not Eligible for TransplantCompletedNCT03106324
- Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)CompletedNCT03098589
- A Study to Assess the Pharmacokinetics of CC-122 in Subjects With Mild, Moderate, and Severe Renal ImpairmentCompletedNCT03097016Phase 1
- Clinical and Economic Outcomes of Oral Anticoagulants in Non-valvular Atrial FibrillationCompletedNCT03087487
- Treatment of Venous Thromboembolism in Real-Life PatientsCompletedNCT03087474
- Real-world Incidence Proportion of Hepatic Toxicity and All Adverse Drug Reactions (ADRs) in Japanese Patients Receiving Daclatasvir (DCV) Trio TherapyCompletedNCT03071133
- A Single Ascending Dose Study Assessing the Safety, Tolerability, PK and PD of MYK-491CompletedNCT03062956Phase 1
- Relative Bioavailability of BMS-931699 From Prefilled Syringe Compared to Drug in VialTerminatedNCT03058822Phase 1
- A Safety Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Non-small Cell Lung CancerWithdrawnNCT03048136Phase 3
- Determining Change in Cardiovascular and Metabolic Risks in Patients With Chronic Phase Chronic Myeloid Leukemia Receiving BCR-ABL Tyrosine Kinase Inhibitor First-Line Therapy in the United StatesCompletedNCT03045120
- Effect of BMS-986165 on the Pharmacokinetics of RosuvastatinCompletedNCT03044873Phase 1